Light can destroy cancer cells, but only if drugs activated by that light are present in sufficient quantities within the tumor. This seemingly simple requirement has complicated photodynamic therapy since its inception. Without a way to directly measure drug activation and cell death, doctors must estimate when to shine light on tumors based on approximate drug accumulation times. These estimates often lead to mistimed treatments - either too early when insufficient drug is present, or too late when the opportunity for maximum impact has passed.
